Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 8/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.52 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.52 |
| ▸ | AXL | P30530 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5527335 | 0.96 | CYP2A6 (0.60) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL1690651 | 0.96 | CYP2A6 (0.65) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL5531359 | 0.91 | CYP19A1 (0.56) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL12373173 | 0.90 | NPY5R (0.58) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL31508264 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL12956908 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL12108682 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL12068478 | 0.89 | CYP2A6 (0.83) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL22137845 | 0.88 | CYP2A6 (0.60) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 | |
| SCHEMBL8882222 | 0.87 | CYP2A6 (0.54) | CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020130613-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 두산솔루스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020130613-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 두산솔루스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2019-10-24 | — | — | US | disclosed |
| EP-2445881-B1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | BOE TECHNOLOGY GROUP CO LTD (CN) | 2017-11-15 | — | — | EP | disclosed |
| EP-2445881-B1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | BOE TECHNOLOGY GROUP CO LTD (CN) | 2017-11-15 | — | — | EP | disclosed |
| US-8865905-B2 | Organic compounds | GENERAL ELECTRIC COMPANY (US) | 2014-10-21 | — | — | US | disclosed |
| US-8865905-B2 | Organic compounds | GENERAL ELECTRIC COMPANY (US) | 2014-10-21 | — | — | US | disclosed |
| US-8865905-B2 | Organic compounds | GENERAL ELECTRIC COMPANY (US) | 2014-10-21 | — | — | US | disclosed |
| US-20130217882-A1 | ORGANIC COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2013-08-22 | — | — | US | disclosed |
| US-20130217882-A1 | ORGANIC COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2013-08-22 | — | — | US | disclosed |
| US-20120178938-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2012-07-12 | — | — | US | disclosed |
| US-20120178938-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2012-07-12 | — | — | US | disclosed |
| US-20120178938-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2012-07-12 | — | — | US | disclosed |
| US-8178682-B2 | Process for making organic compounds and the organic compounds made therefrom | GENERAL ELECTRIC COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| US-8178682-B2 | Process for making organic compounds and the organic compounds made therefrom | GENERAL ELECTRIC COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| US-8178682-B2 | Process for making organic compounds and the organic compounds made therefrom | GENERAL ELECTRIC COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| US-20100331547-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100331547-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100331547-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2010-12-30 | — | — | US | disclosed |
| WO-2010151389-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331547-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | CYP4F11, BCL6, CYP2F1 | CYP2A6 41/4885ALDH1A1 2404/4885CYP3A4 94/4885 |
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | DRD2, GRIN2D, DRD1 | CYP2A6 1673/4885ALDH1A1 1377/4885CYP3A4 2143/4885 |
| US-20120178938-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | CYP2F1, CYP4F2, CYP1B1 | CYP2A6 30/4885ALDH1A1 583/4885CYP3A4 96/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.